Not applicableStudy completedNCT03045419What this trial is testingAdded Value of Gadoxetic Acid-enhanced Liver MRIWho this might be right forHccDiagnosis Seoul National University Hospital 130
Not applicableStudy completedNCT03782207What this trial is testingA Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical PracticeWho this might be right forUrothelial CarcinomaNon-Small Cell Lung CancerSmall Cell Lung Cancer+1 more Hoffmann-La Roche 2,756
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Early research (Phase 1)Ended earlyNCT04116320What this trial is testingFocused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsWho this might be right forMelanomaBreast CancerMerkel Cell Carcinoma+10 more Craig L Slingluff, Jr 5
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Large-scale testing (Phase 3)Looking for participantsNCT07381660What this trial is testingSBRT Versus Surgical Resection for Small HCCWho this might be right forHepatocellular Carcinoma (HCC) Sun Yat-sen University 390
Testing effectiveness (Phase 2)UnknownNCT03475953What this trial is testingA Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsWho this might be right forColorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more Institut Bergonié 747
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Not applicableEnded earlyNCT04106167What this trial is testingLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyWho this might be right forAdvanced Solid TumorLymphomaGastric Cancer+15 more Fate Therapeutics 20
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT04242199What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more Incyte Corporation 182
Not applicableStudy completedNCT00957424What this trial is testingAcceptability of Less Harmful Alternatives to CigarettesWho this might be right forBladder CancerCervical CancerEsophageal Cancer+8 more Roswell Park Cancer Institute 67
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Not applicableActive Not RecruitingNCT06618300What this trial is testingStreamlined Resin Y90 Radiation Segmentectomy for Small HCCWho this might be right forHepatocellular Carcinoma (HCC) UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT05212922What this trial is testingEvaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCCWho this might be right forHCCNSCLC Stage IIIBNSCLC Stage IV Eucure (Beijing) Biopharma Co., Ltd
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT04943900What this trial is testingBMS-986416 With and Without Nivolumab in Select Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 67
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7